---
title: "adalimumab - Ankylosing spondylitis"
sidebar: mydoc_sidebar
permalink: adalimumabankylosingspondylitis.html
toc: false 
---

{% include image.html file="adalimumabankylosingspondylitis.png" alt="adalimumabankylosingspondylitis" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000068879 | adalimumab | Drug |
| UniProt:P01375 | Tumor necrosis factor | Protein |
| REACT:R-HSA-75893 | TNF signaling | Pathway |
| GO:0006954 | inflammation | BiologicalProcess |
| MESH:D013167 | Ankylosing spondylitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Adalimumab | DECREASES ACTIVITY OF | Tumor Necrosis Factor |
| Tumor Necrosis Factor | PARTICIPATES IN | Tnf Signaling |
| Tnf Signaling | POSITIVELY REGULATES | Inflammation |
| Inflammation | CAUSES | Ankylosing Spondylitis |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00051#mechanism-of-action](https://go.drugbank.com/drugs/DB00051#mechanism-of-action){:target="_blank"}